The development and validation of a liquid chromatography tandem mass spectrometry method for the quantification of selinexor and its application in Chinese multiple myeloma patients

A UPLC-MS/MS method has been developed for the determination of selinexor concentration in human plasma, and the correlations between plasma drug concentration and some adverse events have also been explored.